The following 10 news items were last checked at 12:56 AM on 5/24/13.
News feeds provided by University Communications, UW-Madison.
With the help of a solitary sea squirt, scientists have resolved the longstanding puzzle of the crystal structure of vaterite, an enigmatic geologic mineral and biomineral.
To help bio newbies get off to the right start, as many as 130 students will begin 2014 in BioHouse, the university’s 10th residential learning community.
As a new type of "bird flu" causes deaths and worries in China, a Madison startup is attacking the problem on two fronts. FluGen, under the scientific guidance of University of Wisconsin-Madison researcher Yoshihiro Kawaoka, a world authority on influenza, is moving ahead with a better way to deliver existing vaccines and a novel "universal" flu vaccine.
At a time when scientists are beginning to recognize the pervasive influence of microbes in a legion of plant and animal functions, new research shows a symbiotic bacterium setting the biological clock of its host animal.
The age at which a child with autism is diagnosed is related to the particular suite of behavioral symptoms he or she exhibits, new research from the University of Wisconsin-Madison shows.
World leaders in the use of stem cells will gather Wednesday, April 10 at the BioPharmaceutical Technology Center Institute in Fitchburg, Wis., for the eighth annual Wisconsin Stem Cell Symposium, "Cell-Based Therapy for Heart & Vascular Disease: Pathways to Clinic."
The U.S. Department of Energy (DOE) has awarded the University of Wisconsin-Madison $25 million per year to fund the Great Lakes Bioenergy Research Center (GLBRC) for another five years.
Gazing out at the roughly 60,000 cars that cross the intersection at the Wisconsin Energy Institute’s (WEI’s) doorstep, the reason the building exists is clear — energy consumption and dependence on fossil fuels — and WEI’s research is poised to address the problem.
After a voluntary hiatus of more than a year, avian influenza transmission studies may soon resume at UW-Madison’s Influenza Research Institute (IRI) as the National Institutes of Heath (NIH) last week issued a new framework for vetting such experiments.
Researchers at the University of Wisconsin-Madison have found a new way to accelerate a workhorse instrument that identifies proteins. The high-speed technique could help diagnose cancer sooner and point to new drugs for treating a wide range of conditions.